New Method for Detection Ischemic Heart Cell Damage

检测缺血性心脏细胞损伤的新方法

基本信息

  • 批准号:
    63870037
  • 负责人:
  • 金额:
    $ 5.95万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B).
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

Fatty acid binding protein (FABP) is thought to play an important role as a carrier protein in intracellular transportation of fatty acids and lipid metabolism. It accounts for several percentage of soluble protein. Because the molecular weight of FABP is low (mol wt 14000), it may be released from the cells in case of the hypoxic myocyte as a maker of the hypoxic cell injury. New born rat myocytes were incubated under hypoxic treatment for 6 hrs, then the release of FABP and CPK were measured. Delipidation of samples and assay of fatty acid binding were carried out using a Lipidex 1000, according to the method of Glatz et al.. Lipidex 1000, a 10% (w/w) substituted hydroxyalkoxypropyl derivative of Sephadex G-25, removes unbound fatty acids from protein-fatty acid complexes at 0^゚C, and removes all fatty acids at 37^゚C from aqueous solutions according to protein-lipid interaction kinetics. For delipidation, samples (30mg) were subjected to chromatography on the Lipidex column (1.5 x 7 … More cm) equilibrated with 10mM sodium phosphate buffer (pH 7.4) at 37^゚C. The column was eluted with the same buffer and all the proteins were recovered in the void bolume. For the assay of fatty acid binding, samples were incubated with various concentrations of 14C-labeled fatty acids (Amersham ; Arlington Heights, IL) in a polyethylene tube in 10 mM sodium phosphate buffer (pH 7.4 ; final volume 0.45ml) for 10 min at 37 C. Then, to remove unbound fatty acids, the tubes were cooled on ice and ice-cold Lipidex/buffer suspension (1 : 1 v/v ; 0.05ml) was added and incubated for another 10min at 0^゚C. Fatty acid binding was calculated from the amount of radioactivity present in the supernatant after centrifugation of the tubes, and was expressed as pmol/ug of protein.The cell death ratio during hypoxygenation increased since 4 h and rose to 80% at 6 h, but it was only 8% under aerobic conditions. FABP was detected at 1 h, rapidly increased and reached plateau at 4 h. On the other hand CPK release was negligible during 6h. Ca-antagonist and blocker inhibited the release of FABP and prevented the cell death. These result shows FABP is of use as a maker of myocardial cell injury, and hypoxic cell injury is mediated through adrenergic receptor. Less
脂肪酸结合蛋白(FABP)作为一种载体蛋白,在脂肪酸的细胞内转运和脂质代谢中起着重要作用。它占可溶性蛋白质的几个百分比。由于FABP的分子量较低(mol wt 14000),在缺氧心肌细胞的情况下,其可以从细胞中释放,作为缺氧细胞损伤的标志物。新生大鼠心肌细胞缺氧培养6小时,测定FABP和CPK的释放。根据Glatz等人的方法,使用Lipidex 1000进行样品脱脂和脂肪酸结合测定。Lipidex 1000是Sephadex G-25的10%(w/w)取代羟基烷氧丙基衍生物,可在0 ° C下从蛋白质-脂肪酸复合物中去除未结合的脂肪酸,并根据蛋白质-脂质相互作用动力学在37 ° C下从水溶液中去除所有脂肪酸。对于脱脂,将样品(30 mg)在Lipidex柱(1.5 x 7)上进行色谱分析 ...更多信息 cm),在37 ° C下用10 mM磷酸钠缓冲液(pH 7.4)平衡。用相同的缓冲液洗脱柱,并将所有蛋白质回收到空柱中。对于脂肪酸结合的测定,将样品与不同浓度的14 C-标记的脂肪酸(阿默舍姆;阿灵顿Heights,IL)在聚乙烯管中的10 mM磷酸钠缓冲液(pH7.4;终体积0.45 ml)中于37 ℃温育10分钟。然后,为了除去未结合的脂肪酸,将管在冰上冷却,加入冰冷的Lipidex/缓冲液悬浮液(1:1 v/v ; 0.05ml),并在0 ° C下再孵育10分钟。脂肪酸结合率由离心管后上清液中的放射性量计算,并表示为pmol/ug蛋白质。缺氧期间的细胞死亡率从4 h开始增加,6 h时上升至80%,但在有氧条件下仅为8%。FABP在1h检测到,迅速升高,4 h达平台期。另一方面,CPK释放在6小时内可忽略不计。Ca ~(2+)拮抗剂和阻断剂可抑制FABP的释放,防止细胞死亡。提示FABP是心肌细胞损伤的标志物,缺氧性心肌细胞损伤是通过肾上腺素能受体介导的。少

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoshi Fujii: "Isolation and partial characterization of an amphiphilic 56ーKDa fatty acid binding protein from rat renal basolateral membnane" J.Biochemistry. 101. 179-184 (1987)
Satoshi Fujii:“大鼠肾基底外侧膜两亲性 56-KDa 脂肪酸结合蛋白的分离和部分表征”J.Biochemistry 101. 179-184 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoshi Fujii: "Increased renal fatty acid binding protein of in spontaneously hypertensive rats" J. Hypertension. vol 6. 671-675 (1988)
Satoshi Fujii:“自发性高血压大鼠肾脂肪酸结合蛋白增加”J.高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoshi Fujii: "Fatty acid binding protein of cardiac muscle in the spontaneously hypertensive rat : effect of hypertrophy and its regression" J Mol Cell Cardiol. vol 20. 779-787 (1988)
Satoshi Fujii:“自发性高血压大鼠心肌的脂肪酸结合蛋白:肥厚及其消退的影响”J Mol Cell Cardiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoshi Fujii: "Purification of high affinity fatty acid reeeptors in rat myocardial Sarcolemmal membranes" LiPids. 22. 544-546 (1987)
Satoshi Fujii:“大鼠心肌肌膜膜中高亲和力脂肪酸受体的纯化”LiPids。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoshi Fujii: "Fatty acid biding protein of cardiac muscle in the spontaneously hypertensiverat:effect of hypertrophy and its regression" Journal of Molecular and Cellular Cardiology. 20. 779-787 (1988)
Satoshi Fujii:“自发性高血压大鼠心肌的脂肪酸结合蛋白:肥厚及其消退的影响”分子和细胞心脏病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YASUDA Hisakazu其他文献

YASUDA Hisakazu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YASUDA Hisakazu', 18)}}的其他基金

Development of Noninvasive Ultrasonic Measurement Device for Visco-elastic Properties of Vessel Wall
血管壁粘弹性无创超声测量装置的研制
  • 批准号:
    59870031
  • 财政年份:
    1984
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似海外基金

MICA: Determining the therapeutic potential of targeting the free fatty acid receptors FFA1 and FFA4 in human lung inflammatory disease
MICA:确定靶向游离脂肪酸受体 FFA1 和 FFA4 在人类肺部炎症性疾病中的治疗潜力
  • 批准号:
    MR/X010198/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Research Grant
Alterations in Unbound Free Fatty Acid Profiles in CVD
CVD 中未结合游离脂肪酸谱的变化
  • 批准号:
    10761556
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
Mechanisms of free fatty acid receptor 4 signaling in the ischemic myocardium
缺血心肌中游离脂肪酸受体4信号传导机制
  • 批准号:
    10447568
  • 财政年份:
    2020
  • 资助金额:
    $ 5.95万
  • 项目类别:
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury
游离脂肪酸受体4对心脏缺血性损伤的心脏保护作用
  • 批准号:
    10614417
  • 财政年份:
    2020
  • 资助金额:
    $ 5.95万
  • 项目类别:
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury
游离脂肪酸受体4对心脏缺血性损伤的心脏保护作用
  • 批准号:
    10386829
  • 财政年份:
    2020
  • 资助金额:
    $ 5.95万
  • 项目类别:
Does free fatty acid receptor 1 FFAR1 contribute to the development of chronic pain-associated depression ?
游离脂肪酸受体 1 FFAR1 是否会导致慢性疼痛相关抑郁症的发生?
  • 批准号:
    19K09512
  • 财政年份:
    2019
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining physiological and pathophysiological roles of the Free Fatty Acid Receptor2 by analysis of novel transgenic mouse models
通过分析新型转基因小鼠模型定义游离脂肪酸受体2的生理和病理生理作用
  • 批准号:
    BB/S000453/1
  • 财政年份:
    2018
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Research Grant
MICA: Defining the functional modes of action, and therapeutic potential of targeting, the free fatty acid receptor FFA4 in the lung.
MICA:定义作用的功能模式以及靶向肺部游离脂肪酸受体 FFA4 的治疗潜力。
  • 批准号:
    MR/R00305X/1
  • 财政年份:
    2018
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Research Grant
The role of brain free fatty acid receptor GPR40/FFAR1 signaling in chronic pain
脑游离脂肪酸受体 GPR40/FFAR1 信号在慢性疼痛中的作用
  • 批准号:
    18K08836
  • 财政年份:
    2018
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
the analysis of relationship between fatty acids and bone metabolism in free fatty acid receptor GPR120 knockout mice.
游离脂肪酸受体GPR120基因敲除小鼠脂肪酸与骨代谢的关系分析
  • 批准号:
    18K09850
  • 财政年份:
    2018
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了